Hudson Bay Capital Management’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Hudson Bay Capital Management’s Portfolio DMIIR Stock Details DMIIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$61.3K	Sell	1,091,534 -222,514	-17%	-$17.3K	﹤0.01%	1157
2026 Q2	$95.5K	Sell	1,314,048 -391,302	-23%	-$33.5K	﹤0.01%	1169
2026 Q1	$136K	Sell	1,705,350 -263,680	-13%	-$30K	﹤0.01%	1153
2025 Q4	$276K	Buy	+1,969,030	New	+$281K	﹤0.01%	931

Other funds holding DMIIR

MMCAP International Grand Cayman, Cayman Islands $1.52B AUM 24.83% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

OMERS Administration Corp Toronto, Ontario, Canada $16.3B AUM 28.35% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

MCS

Mercuria Capital Strategies Houston, Texas $175M AUM 247.9% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $447M AUM 5.09% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return

Hudson Bay Capital Management's DMIIR Position: Q3 2026 in Review

Hudson Bay Capital Management reduced its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 17% in Q3 2026, selling an estimated $17.3K and leaving 1,091,534 shares worth $61.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1157.

Hudson Bay Capital Management first reported a position in DMIIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $276K in Q4 2025. 28 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

Hudson Bay Capital Management held 1,091,534 shares of Drugs Made In America Acquisition II Corp Right worth $61.3K as of Q3 2026.
Hudson Bay Capital Management sold 222,514 Drugs Made In America Acquisition II Corp Right shares in Q3 2026, an estimated $17.3K.
Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q3 2026, its #1157 holding.
Hudson Bay Capital Management first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 4 quarters since.
Hudson Bay Capital Management's Drugs Made In America Acquisition II Corp Right position peaked at $276K in Q4 2025.
28 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on Hudson Bay Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.